Search Results 971-980 of 21357 for anti-TNF drugs

  1. Immune checkpoint inhibitors and thyroid dysfunction: A case from the endocrine teaching clinics - Mayo Clinic

    Occasionally, a low TSH may indicate the presence of a central process consistent with immune therapy-induced hypophysitis. Hypophysitis is uncommon with anti- ...

  2. Thioxanthene (Oral Route, Parenteral Route) Before Using - Mayo Clinic

    Be sure you have discussed the risks and benefits of this medicine with your doctor. Drug Interactions. Although certain medicines should not be used together ...

  3. Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer - Mayo Clinic

    ... TNF] agents) within 4 weeks prior to cycle 1, day ... drugs); replacement therapy ... A stable regimen of highly active anti-retroviral therapy (HAART) ...

  4. Probenecid (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  5. Antiphospholipid syndrome - Symptoms & causes - Mayo Clinic

    Learn about causes and treatment of this blood disorder that mainly affects women and may cause blood clots and miscarriages.

  6. Dextroamphetamine (Transdermal Route) Description and Brand Names - Mayo Clinic

    Dextroamphetamine transdermal patch is used to treat attention-deficit hyperactivity disorder (ADHD). It belongs to the group of medicines called central ...

  7. Analgesic Combination, Acetaminophen/Salicylate (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  8. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... Subject who received IV anti-infectives within 35 days prior to ...

  9. Inebilizumab-Cdon (Intravenous Route) Description and Brand Names - Mayo Clinic

    Drugs and Supplements · Inebilizumab-Cdon ... It is used in patients who are anti-aquaporin-4 (AQP4) antibody positive. ... Drugs & Supplements ...

  10. Glycopyrrolate (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...